# Phathom Pharmaceuticals, Inc. (PHAT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PHAT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 58.30M | $ -30.37M | $ -15.65M | N/A | $ -336.96M |
| 2025 | $ 179.30M | $ -226.54M | $ -170.69M | $ 2.71M | $ -438.17M |
| 2024 | $ 58.07M | $ -351.40M | $ -280.40M | $ 554.95M | $ -253.58M |
| 2023 | $ 737.4K | $ -217.97M | $ -150.53M | $ 139.03M | $ -72.76M |
| 2022 | $ 0 | $ -220.88M | $ -164.47M | $ 97.07M | $ -74.81M |
| 2021 | $ 0 | $ -171.03M | $ -177.04M | $ 91.34M | $ 72.16M |
| 2020 | $ 0 | $ -164.42M | $ -90.10M | $ 49.02M | $ 194.27M |
| 2019 | $ 0 | $ -329.31M | $ -47.30M | $ 23.57M | $ 227.96M |
| 2018 | $ 0 | $ -1.70M | $ -1.35M | $ 1.95M | $ -1.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.91 |
| Current Ratio | 2.21 |

## Other views

- [Metrics](https://sponda.capital/en/PHAT.md)
- [Charts](https://sponda.capital/en/PHAT/charts.md)
- [Compare](https://sponda.capital/en/PHAT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.